ER-positive breast cancer is a rapidly developing disease. In this episode of #OncologyWatch, we addressed some important questions to optimize the adjuvant endocrine therapy for early breast cancer with our experts: Prof. Mohsen Mokhtar, Prof. Shaheena Dawood and moderated by Dr. Hazem ElMansy.
.png)
.png)
